Biotech regulatory gaps

5 items 1 source

Absence of clear regulatory guidance from bodies like MHRA for genetically engineered (GE) phages and enzymes.

Biotech regulatory gaps has been flagged across 1 independent accountability source:

5 PFD reports

This theme has been identified in one data source. As more data is added, cross-references may emerge.

Concerns: There is a lack of understanding regarding the dangers of e-bike/e-scooter lithium-ion batteries and chargers, coupled with an absence of British or European safety standards.

Concerns: Despite DNP's toxicity and planned reclassification as a poison, there's no clear government department or organisation designated to monitor and prevent its sale for human consumption, risking further deaths.

Concerns: Current regulations for Crash Resistant Fuel Systems (CRFS) in rotorcraft are inadequate, failing to mandate retrofits or provide a public register. This leaves a high risk of post-crash fires and prevents informed public decision-making.

Concerns: The drug involved, and several of its chemical compounds, were not fully controlled by legislation, leading to regulatory gaps and potential public health risks.

Concerns: Concerns were raised regarding the easy online availability and regulation of chloroquine, along with the associated risks of its misuse.